Ketamine's Effects on the Glutamatergic and GABAergic Systems: A Proteomics and Metabolomics Study in Mice.

Saved in:
Bibliographic Details
Title: Ketamine's Effects on the Glutamatergic and GABAergic Systems: A Proteomics and Metabolomics Study in Mice.
Authors: Weckmann K; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany.; Institute for Pathobiochemistry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Deery MJ; Cambridge Centre for Proteomics, Cambridge System Biology Centre, University of Cambridge, Cambridge, United Kingdom., Howard JA; Cambridge Centre for Proteomics, Cambridge System Biology Centre, University of Cambridge, Cambridge, United Kingdom., Feret R; Cambridge Centre for Proteomics, Cambridge System Biology Centre, University of Cambridge, Cambridge, United Kingdom., Asara JM; Division of Signal Transduction, Beth Israel Deaconess Medical Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Dethloff F; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany., Filiou MD; Department of Biological Applications and Technology, School of Health Sciences, University of Ioannina, Ioannina, Greece., Labermaier C; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany., Maccarrone G; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany., Lilley KS; Cambridge Centre for Proteomics, Cambridge System Biology Centre, University of Cambridge, Cambridge, United Kingdom., Mueller M; Experimental Psychiatry, Department of Psychiatry and Psychotherapy and Focus Program Translational Neuroscience, Johannes Gutenberg University Medical Center, Mainz, Germany., Turck CW; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany.
Source: Molecular neuropsychiatry [Mol Neuropsychiatry] 2019 Mar; Vol. 5 (1), pp. 42-51. Date of Electronic Publication: 2018 Nov 15.
Publication Type: Journal Article
Journal Info: Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101649121 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2296-9209 (Print) Linking ISSN: 22969179 NLM ISO Abbreviation: Mol Neuropsychiatry Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31019917
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ketamine's Effects on the Glutamatergic and GABAergic Systems: A Proteomics and Metabolomics Study in Mice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Weckmann+K%22">Weckmann K</searchLink>; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany.; Institute for Pathobiochemistry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Deery+MJ%22">Deery MJ</searchLink>; Cambridge Centre for Proteomics, Cambridge System Biology Centre, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Howard+JA%22">Howard JA</searchLink>; Cambridge Centre for Proteomics, Cambridge System Biology Centre, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Feret+R%22">Feret R</searchLink>; Cambridge Centre for Proteomics, Cambridge System Biology Centre, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Asara+JM%22">Asara JM</searchLink>; Division of Signal Transduction, Beth Israel Deaconess Medical Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Dethloff+F%22">Dethloff F</searchLink>; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Filiou+MD%22">Filiou MD</searchLink>; Department of Biological Applications and Technology, School of Health Sciences, University of Ioannina, Ioannina, Greece.<br /><searchLink fieldCode="AU" term="%22Labermaier+C%22">Labermaier C</searchLink>; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Maccarrone+G%22">Maccarrone G</searchLink>; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Lilley+KS%22">Lilley KS</searchLink>; Cambridge Centre for Proteomics, Cambridge System Biology Centre, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Mueller+M%22">Mueller M</searchLink>; Experimental Psychiatry, Department of Psychiatry and Psychotherapy and Focus Program Translational Neuroscience, Johannes Gutenberg University Medical Center, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Turck+CW%22">Turck CW</searchLink>; Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101649121%22">Molecular neuropsychiatry</searchLink> [Mol Neuropsychiatry] 2019 Mar; Vol. 5 (1), pp. 42-51. <i>Date of Electronic Publication: </i>2018 Nov 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22S%2E+Karger%22">S. Karger </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101649121 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2296-9209 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222969179%22">22969179 </searchLink><i>NLM ISO Abbreviation: </i>Mol Neuropsychiatry <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31019917
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1159/000493425
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 42
    Titles:
      – TitleFull: Ketamine's Effects on the Glutamatergic and GABAergic Systems: A Proteomics and Metabolomics Study in Mice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Weckmann K
      – PersonEntity:
          Name:
            NameFull: Deery MJ
      – PersonEntity:
          Name:
            NameFull: Howard JA
      – PersonEntity:
          Name:
            NameFull: Feret R
      – PersonEntity:
          Name:
            NameFull: Asara JM
      – PersonEntity:
          Name:
            NameFull: Dethloff F
      – PersonEntity:
          Name:
            NameFull: Filiou MD
      – PersonEntity:
          Name:
            NameFull: Labermaier C
      – PersonEntity:
          Name:
            NameFull: Maccarrone G
      – PersonEntity:
          Name:
            NameFull: Lilley KS
      – PersonEntity:
          Name:
            NameFull: Mueller M
      – PersonEntity:
          Name:
            NameFull: Turck CW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2019 Mar
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 2296-9209
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Molecular neuropsychiatry
              Type: main
ResultId 1